Università degli Studi di Milano - Centro di ricerca sulle cellule staminali

Symposium “Hematological Malignancies”

9th -12th March 2016

Schermata 2016-01-20 alle 15.24.36

As the field of onco-hematology is constantly, often turbulently, evolving, the promotion of meetings that allow researchers to compare and share information, transferring acquisitions obtained from the study of the genome to the bedside, is crucial and can lead to the development of innovative personalized treatments with highest therapeutic effect and lowest toxicity burden. In this context, we believe that a discussion on the state of the art of blood and lymphatic tissue cancers could represent an important scientific, cultural and informative contribution of the national and international medical community, in the year in which the World Health Organization is preparing to publish guidelines for the – increasingly molecular – diagnosis and treatment of such conditions.

 

Registration deadline: February 12, 2016 The number of participants is limited to 120
For further information and registration: www.hematologysymposium2016.eu, hematology2016@ieo.eu

 

SCIENTIFIC COMMITTEE

Francesco Bertolini,
European Institute of Oncology, Milan, Italy

Riccardo Dalla Favera,
Columbia University, New York, New York, USA

Francesco Lo Coco,
Università Tor Vergata, Rome, Italy

Pier Giuseppe Pelicci,
European Institute of Oncology, Milan, Italy

Stefano A. Pileri,
European Institute of Oncology, Milan, Italy

Corrado Tarella,
European Institute of Oncology, Milan, Italy

KEYNOTE LECTURERS

Michael Stratton,
Wellcome Trust Sanger Institute, Hinxton, UK

Stefano A. Pileri,
European Institute of Oncology, Milan, Italy

Felice Bombaci,
Patient Advocate, Gruppo AIL Pazienti Leucemia Mieloide Cronica, Rome, Italy

POSTED ON 21 January 2016 - TAG: